UT Southwestern Medical Center
UT Southwestern Medical Center
Dallas, Texas, United States5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder | Chemically-Induced Disorders, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 2 | 2026-09-23 | NCT07825857 | |
| Ketamine for Methamphetamine Use Disorder | Chemically-Induced Disorders, Substance Use, Substance Use Disorders, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 2 | 2026-09-21 | NCT06496750 | |
| Accelerated rTMS for Substance Use Disorder and Depression | depressive disorder | Recruiting | Not applicable | 2026-08-24 | NCT06424184 | |
| An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Enrolling by invitation | Phase 2 | 2026-08-21 | NCT07693608 | |
| Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Fatigue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleepiness, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Enrolling by invitation | Phase 1 | 2025-12-31 | NCT06261528 |